FI832730A0 - Trifenylimidazolyloxialkansyror och derivat daerav samt foerfaranden foer deras framstaellning - Google Patents

Trifenylimidazolyloxialkansyror och derivat daerav samt foerfaranden foer deras framstaellning

Info

Publication number
FI832730A0
FI832730A0 FI832730A FI832730A FI832730A0 FI 832730 A0 FI832730 A0 FI 832730A0 FI 832730 A FI832730 A FI 832730A FI 832730 A FI832730 A FI 832730A FI 832730 A0 FI832730 A0 FI 832730A0
Authority
FI
Finland
Prior art keywords
trifenylimidazolyloxialkansyror
derivat
och
deras framstaellning
foer deras
Prior art date
Application number
FI832730A
Other languages
English (en)
Other versions
FI79302C (fi
FI832730A (fi
FI79302B (fi
Inventor
Hans-Heiner Lautenschlaeger
Andre Welter
Gerd Hilboll
Johannes Winkelmann
Gerrit Prop
Axel Brekle
Ottfried Zierenberg
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of FI832730A0 publication Critical patent/FI832730A0/fi
Publication of FI832730A publication Critical patent/FI832730A/fi
Application granted granted Critical
Publication of FI79302B publication Critical patent/FI79302B/fi
Publication of FI79302C publication Critical patent/FI79302C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI832730A 1982-07-29 1983-07-28 Foerfarande foer framstaellning av farmakologiskt aktiva trifenylimidazolyloxialkansyror och derivat daerav. FI79302C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3228271A DE3228271A1 (de) 1982-07-29 1982-07-29 Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3228271 1982-07-29

Publications (4)

Publication Number Publication Date
FI832730A0 true FI832730A0 (fi) 1983-07-28
FI832730A FI832730A (fi) 1984-01-30
FI79302B FI79302B (fi) 1989-08-31
FI79302C FI79302C (fi) 1989-12-11

Family

ID=6169571

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832730A FI79302C (fi) 1982-07-29 1983-07-28 Foerfarande foer framstaellning av farmakologiskt aktiva trifenylimidazolyloxialkansyror och derivat daerav.

Country Status (13)

Country Link
US (1) US4460598A (fi)
EP (1) EP0104342B1 (fi)
JP (1) JPS5951269A (fi)
AT (1) ATE25246T1 (fi)
DE (2) DE3228271A1 (fi)
DK (1) DK158723C (fi)
ES (1) ES8404332A1 (fi)
FI (1) FI79302C (fi)
GR (1) GR78654B (fi)
IE (1) IE55485B1 (fi)
NO (1) NO160579C (fi)
PT (1) PT77125B (fi)
ZA (1) ZA834648B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323870A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-ylthioalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4598149A (en) * 1984-03-02 1986-07-01 Merck & Co., Inc. 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
DE3504677A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-yloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3504678A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung
DE3504679A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Amide der 2-imidazolyloxyalkansaeuren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3504680A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue ether des 2-hydroxyimidazols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPH0680057B2 (ja) * 1986-04-28 1994-10-12 保土谷化学工業株式会社 トリフエニルイミダゾ−ル及びその二量体
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
US4900744A (en) * 1988-09-14 1990-02-13 E. I. Du Pont De Nemours And Company Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles
US5166214A (en) * 1988-12-05 1992-11-24 Du Pont Merck Pharmaceutical Company Use of imidazoles for the treatment of atherosclerosis
CA2014537A1 (en) * 1989-04-26 1990-10-26 Yoshio Hayashi 4-imidazoline derivatives
US5019572A (en) * 1990-02-07 1991-05-28 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US4994482A (en) * 1989-07-31 1991-02-19 Bristol-Myers Squibb Company Arylpyrazol derivatives as anti-platelet agents, compositions and use
US5262540A (en) * 1989-12-20 1993-11-16 Bristol-Myers Squibb Company [2(4,5-diaryl-2 oxazoyl substituted phenoxy alkanoic acid and esters
US5152988A (en) * 1990-02-07 1992-10-06 Merck & Co., Inc. Imidazole compounds in compositions and methods in thrombolytic therapy
US5011851A (en) * 1990-02-13 1991-04-30 Bristol-Myers Squibb Co. Imidazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith
EP0442448A3 (en) 1990-02-13 1992-08-12 Bristol-Myers Squibb Company Heterocyclic carboxylic acids and esters
GB9019838D0 (en) * 1990-09-11 1990-10-24 Smith Kline French Lab Compounds
US5428041A (en) * 1991-05-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof
US5179117A (en) * 1991-12-20 1993-01-12 Du Pont Merck Pharmaceutical Company Antihypercholesterolemic 2-substituted imidazoles
JP2001527506A (ja) * 1992-02-11 2001-12-25 スミスクライン・ビーチャム・コーポレイション CoA−ITおよびPAF阻害剤
US5254576A (en) * 1992-04-03 1993-10-19 Bristol-Myers Squibb Company Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US5187188A (en) * 1992-04-03 1993-02-16 Bristol-Myers Squibb Company Oxazole carboxylic acid derivatives
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5362879A (en) * 1993-04-15 1994-11-08 Bristol-Myers Squibb Company 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation
SE527381C3 (sv) * 2003-04-14 2006-03-21 Linnman Elektronik Ab Gemensam fältbuss för överföring av data och energi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636003A (en) * 1969-11-17 1972-01-18 Geigy Chem Corp Substituted 2-mercaptoimidazole derivatives
DE2934746A1 (de) * 1979-08-28 1981-03-19 A. Nattermann & Cie GmbH, 5000 Köln Oxoimidazolinalkansaeuren, deren salze und ester sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2950478A1 (de) * 1979-12-14 1981-06-19 A. Nattermann & Cie GmbH, 5000 Köln 4,5-diaryl-4-imidazolin-2-on-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3042466A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
NO160579C (no) 1989-05-03
EP0104342A1 (de) 1984-04-04
JPH0456030B2 (fi) 1992-09-07
FI79302C (fi) 1989-12-11
DE3369508D1 (en) 1987-03-05
ATE25246T1 (de) 1987-02-15
ES524512A0 (es) 1984-04-16
DK158723C (da) 1990-12-10
DK346783D0 (da) 1983-07-28
PT77125A (en) 1983-08-01
JPS5951269A (ja) 1984-03-24
PT77125B (en) 1986-01-24
ZA834648B (en) 1984-03-28
NO832630L (no) 1984-01-30
DE3228271A1 (de) 1984-02-02
ES8404332A1 (es) 1984-04-16
GR78654B (fi) 1984-09-27
FI832730A (fi) 1984-01-30
US4460598A (en) 1984-07-17
EP0104342B1 (de) 1987-01-28
DK346783A (da) 1984-01-30
DK158723B (da) 1990-07-09
FI79302B (fi) 1989-08-31
IE831483L (en) 1983-12-29
IE55485B1 (en) 1990-09-26
NO160579B (no) 1989-01-23

Similar Documents

Publication Publication Date Title
FI832730A0 (fi) Trifenylimidazolyloxialkansyror och derivat daerav samt foerfaranden foer deras framstaellning
BE876455A (fr) Procede de therapeutique anxiolytique
BE872336A (fr) Procede d'elimination des sucres flatulents de soja
BR7908175A (pt) Processo para o tratamento de condensado
IT7921594A0 (it) Processo per la preparazione di zeoliti.
RO77553A (ro) Procedeu de preparare a unor acizi tiazol-2-oxamici substituiti
BE881547A (fr) Procede de preparation de d-alpha-amino acides
BE879854A (fr) Procede de preparation de diaryl-para-phenylene-diamines
IT7920824A0 (it) Processo per la preparazione di acidi dienoici.
BE879937A (fr) Procede de preparation d'acides alpha-omega-dicarboxyliques
IT7827827A0 (it) Procedimento per la desalificazione di residui di distilleria.
BE876210A (fr) Procede de production de compositions detergentes
IT7925761A0 (it) Processo per la preparazione di l-alfa-glicerilfosforilcolina.
BE879210A (fr) Procede de preparation de 3-exomethylenecephamsulfoxydes
BE890307A (fr) Procede de preparation de compositions proteiques modifiees
BE878774A (fr) Procede de preparation d'acides carboxyliques, principalement w (w -1) dihydroxyles
IT8019122A0 (it) Metodo e composizione per il trattamento di lenti a contatto.
BR8108547A (pt) Processo para obtencao de acidos fenoxialcanoicos clorados
PT68322B (fr) Processo de preparacao de eteres hidrossoluveis de hidroxi-flavonas.
OA06632A (fr) Procédé de purification de l'isoleucine.
IT8019567A0 (it) Processo per la sterilizzazione dei mammiferi.
IT1113962B (it) Processo per decalcificare pelli
BR8305272A (pt) Composto de 1,2,3,4-tetra-hidro-1-aminometil-4-fenil-isoquinolina e processo de preparacao
IT8120307A0 (it) Disposizione per il trattamento termico di pezzi d'opera.
IE820678L (en) Methylphosphonic acid derivatives

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: A. NATTERMANN & CIE. G.M.B.H